193 related articles for article (PubMed ID: 36053908)
1. Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.
Zhao Z; Simms A; Steinmetz NF
Biomacromolecules; 2022 Oct; 23(10):4379-4387. PubMed ID: 36053908
[TBL] [Abstract][Full Text] [Related]
2. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
Franke CE; Czapar AE; Patel RB; Steinmetz NF
Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
[TBL] [Abstract][Full Text] [Related]
3. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
Lin RD; Steinmetz NF
Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
[TBL] [Abstract][Full Text] [Related]
4. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
Czapar AE; Zheng YR; Riddell IA; Shukla S; Awuah SG; Lippard SJ; Steinmetz NF
ACS Nano; 2016 Apr; 10(4):4119-26. PubMed ID: 26982250
[TBL] [Abstract][Full Text] [Related]
5. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
6. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Synowiec A; Brodaczewska K; Wcisło G; Majewska A; Borkowska A; Filipiak-Duliban A; Gawrylak A; Wilkus K; Piwocka K; Kominek A; Waś H; Lewicki S; Siewiera J; Szczylik C; Szenajch J; Kubiak JZ; Kieda C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982788
[TBL] [Abstract][Full Text] [Related]
8. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
9. Tobacco Mosaic Virus-Based 1D Nanorod-Drug Carrier via the Integrin-Mediated Endocytosis Pathway.
Tian Y; Gao S; Wu M; Liu X; Qiao J; Zhou Q; Jiang S; Niu Z
ACS Appl Mater Interfaces; 2016 May; 8(17):10800-7. PubMed ID: 27062971
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer.
Bortot B; Mongiat M; Valencic E; Dal Monego S; Licastro D; Crosera M; Adami G; Rampazzo E; Ricci G; Romano F; Severini GM; Biffi S
Int J Nanomedicine; 2020; 15():4793-4810. PubMed ID: 32764921
[TBL] [Abstract][Full Text] [Related]
11. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
[TBL] [Abstract][Full Text] [Related]
12. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
[TBL] [Abstract][Full Text] [Related]
13. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer.
Aqil F; Jeyabalan J; Agrawal AK; Kyakulaga AH; Munagala R; Parker L; Gupta RC
Food Funct; 2017 Nov; 8(11):4100-4107. PubMed ID: 28991298
[TBL] [Abstract][Full Text] [Related]
14. Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.
Tsunetoh S; Terai Y; Sasaki H; Tanabe A; Tanaka Y; Sekijima T; Fujioka S; Kawaguchi H; Kanemura M; Yamashita Y; Ohmichi M
Cancer Biol Ther; 2010 Dec; 10(11):1137-46. PubMed ID: 20935474
[TBL] [Abstract][Full Text] [Related]
15. Bioinspired Artificial Tobacco Mosaic Virus with Combined Oncolytic Properties to Completely Destroy Multidrug-Resistant Cancer.
Wu H; Zhong D; Zhang Z; Li Y; Zhang X; Li Y; Zhang Z; Xu X; Yang J; Gu Z
Adv Mater; 2020 Mar; 32(9):e1904958. PubMed ID: 31961987
[TBL] [Abstract][Full Text] [Related]
16. Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio.
Chariou PL; Lee KL; Pokorski JK; Saidel GM; Steinmetz NF
J Phys Chem B; 2016 Jul; 120(26):6120-9. PubMed ID: 27045770
[TBL] [Abstract][Full Text] [Related]
17. Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.
Chariou PL; Wang L; Desai C; Park J; Robbins LK; von Recum HA; Ghiladi RA; Steinmetz NF
Macromol Biosci; 2019 May; 19(5):e1800407. PubMed ID: 30721575
[TBL] [Abstract][Full Text] [Related]
18. High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.
Lee KL; Carpenter BL; Wen AM; Ghiladi RA; Steinmetz NF
ACS Biomater Sci Eng; 2016 May; 2(5):838-844. PubMed ID: 28713855
[TBL] [Abstract][Full Text] [Related]
19. Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo.
Kemnade JO; Seethammagari M; Collinson-Pautz M; Kaur H; Spencer DM; McCormick AA
Vaccine; 2014 Jul; 32(33):4228-33. PubMed ID: 24923637
[TBL] [Abstract][Full Text] [Related]
20. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
Nkanga CI; Ortega-Rivera OA; Steinmetz NF
Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
